Building immunity: biotech faces an onslaught of cyber attacks

Abel Archundia of Istari and Jim Penrose of BlueVoyant describes how biotech and pharmaceutical companies are facing an onslaught of targeted cyber attacks

Copyright Lyonsdown Limited 2020